Phylogica's exciting in-house drug candidates that they've been developing i.e., Neuroprotective peptide inhibitors is something I believe we'll be hearing a lot more about over the coming months.
Note, they are currently in discussions with a "number" of Pharmaceutical companies around potential licensing. Interesting how Nick Woolf mentioned this in the interview.
finance news network interview 13 march, page-4
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.005(2.70%) |
Mkt cap ! $886.5M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.0¢ | 18.0¢ | $125.5K | 667.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 11936 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 40292 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| PYC (ASX) Chart |